Yahoo Web Search

  1. 5 Safe Bets for a Rocky Market

    Zacks via Yahoo FinanceSep 20 20:29 PM

    With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. Zacks Rank #1 ROE 76.17% ROA 11.74% Dividend ...

  2. We'll apply a basic P/E ratio analysis to Amgen Inc.'s (NASDAQ:AMGN), to help you decide if the stock is worth further research. Amgen has a P/E ratio of 15.38, based on ...

  3. Amgen Inc. AMGN announced that a three-drug combination regimen of its multiple myeloma (MM) drug Kyprolis improved progression-free survival (PFS) in a phase III study. The phase ...

  4. Bull of the Day: Amgen (AMGN)

    Zacks via Yahoo FinanceSep 20 10:45 AM

    Amgen (AMGN) is literally one of the world’s biotech pioneers. Founded in California in 1980 and going public three years later, the company – formerly known as American Molecular Genetics ...

  5. 3 Big Biotech Stocks Worth Adding to Your Portfolio Now

    Zacks via Yahoo FinanceSep 20 12:31 PM

    It has been a roller-coaster ride for the biotech sector so far this year. While 2019 started with a bang announcing the mega merger between Bristol-Myers BMY and Celgene CELG that significantly ...

  6. Top Stock Picks for Week of September 16, 2019

    Zacks via Yahoo FinanceSep 16 19:38 PM

    Amgen Inc. AMGN, discovers, develops and delivers innovative human therapeutics. Shares of this Zacks #1, Strong Buy,have risen this year so far, compared with a decline for its industry.

  7. The FDA accepts Seattle Genetics (SGEN) and Astellas' BLA for enfortumab vedotin under a priority review to treat advanced/metastatic urothelial cancer. A verdict is pending on Mar 15, 2020.

  8. X Genomics Inc (NASDAQ: TXG) (listed its shares on Nasdaq on Sept. Alder Biopharmaceuticals Inc (NASDAQ: ALDR) Eidos Therapeutics Inc (NASDAQ: EIDX) IGM Biosciences Inc ...

  9. Stocks recently featured in the blog include: Amgen AMGN, Tokyo Electron TOELY and Kinross Gold KGC. This is a Fed meeting week. With a U.S. consensus forecast for a tad above 2.0% U.S ...

  10. Shares of Alexion Pharmaceuticals, Inc. ALXN were down 4.5% after it announced the departure of its current chief financial officer, Paul Clancy, later this year. Clancy joined Alexion ...

  1. Ad
    related to Amgen Inc